Your browser doesn't support javascript.
loading
Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation.
Alshukairi, Abeer N; Al-Omari, Awad; Al-Tawfiq, Jaffar A; El-Kafrawy, Sherif A; El-Daly, Mai M; Hassan, Ahmed M; Faizo, Arwa A; Alandijany, Thamir A; Dada, Ashraf; Saeedi, Mohammed F; Alhamlan, Fatma S; Al Hroub, Mohammad K; Qushmaq, Ismael; Azhar, Esam I.
Afiliação
  • Alshukairi AN; Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; College of Medicine, AlFaisal University, Riyadh, Saudi Arabia. Electronic address: abeer.alshukairi@gmail.com.
  • Al-Omari A; College of Medicine, AlFaisal University, Riyadh, Saudi Arabia; Department of Critical Care, Dr Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
  • Al-Tawfiq JA; Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins Universi
  • El-Kafrawy SA; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia.
  • El-Daly MM; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia.
  • Hassan AM; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Faizo AA; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia.
  • Alandijany TA; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia.
  • Dada A; College of Medicine, AlFaisal University, Riyadh, Saudi Arabia; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Saeedi MF; Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Alhamlan FS; Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Al Hroub MK; Department of Infection Control and Hospital Epidemiology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Qushmaq I; Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Azhar EI; Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Saudi Arabia.
J Infect Public Health ; 15(6): 628-630, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35576779

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Infect Public Health Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Infect Public Health Ano de publicação: 2022 Tipo de documento: Article